OBJECTIVE: To determine the relationship between the dose to the inner ear or pituitary gland and radiation-induced late effects of skull base radiation therapy. METHODS: 140 patients treated between 2000 and 2008 were considered for this study. Hearing loss and endocrine dysfunction were retrospectively reviewed on pre- and post-radiation therapy audiometry or endocrine assessments. Two normal tissue complication probability (NTCP) models were considered (Lyman-Kutcher-Burman and log-logistic) whose parameters were fitted to patient data using receiver operating characteristics and maximum likelihood analysis. The method provided an estimation of the parameters of a generalized equivalent uniform dose (gEUD)-based NTCP after conversion of dose-volume histograms to equivalent doses. RESULTS: All 140 patients had a minimum follow up of 26 months. 26% and 44% of patients experienced mild hearing loss and endocrine dysfunction, respectively. The fitted values for TD50 and γ50 ranged from 53.6 to 60.7 Gy and from 1.9 to 2.9 for the inner ear and were equal to 60.6 Gy and 4.9 for the pituitary gland, respectively. All models were ranked equal according to Akaike's information criterion. CONCLUSION: Mean dose and gEUD may be used as predictive factors for late ear and pituitary gland late complications after skull base proton and photon radiation therapy. ADVANCES IN KNOWLEDGE: In this study, we have reported mean dose effects and dose-response relationship of small organs at risk (partial volumes of the inner ear and pituitary gland), which could be useful to define optimal dose constraints resulting in an improved therapeutic ratio.
OBJECTIVE: To determine the relationship between the dose to the inner ear or pituitary gland and radiation-induced late effects of skull base radiation therapy. METHODS: 140 patients treated between 2000 and 2008 were considered for this study. Hearing loss and endocrine dysfunction were retrospectively reviewed on pre- and post-radiation therapy audiometry or endocrine assessments. Two normal tissue complication probability (NTCP) models were considered (Lyman-Kutcher-Burman and log-logistic) whose parameters were fitted to patient data using receiver operating characteristics and maximum likelihood analysis. The method provided an estimation of the parameters of a generalized equivalent uniform dose (gEUD)-based NTCP after conversion of dose-volume histograms to equivalent doses. RESULTS: All 140 patients had a minimum follow up of 26 months. 26% and 44% of patients experienced mild hearing loss and endocrine dysfunction, respectively. The fitted values for TD50 and γ50 ranged from 53.6 to 60.7 Gy and from 1.9 to 2.9 for the inner ear and were equal to 60.6 Gy and 4.9 for the pituitary gland, respectively. All models were ranked equal according to Akaike's information criterion. CONCLUSION: Mean dose and gEUD may be used as predictive factors for late ear and pituitary gland late complications after skull base proton and photon radiation therapy. ADVANCES IN KNOWLEDGE: In this study, we have reported mean dose effects and dose-response relationship of small organs at risk (partial volumes of the inner ear and pituitary gland), which could be useful to define optimal dose constraints resulting in an improved therapeutic ratio.
Authors: Shiva K Das; Alan H Baydush; Sumin Zhou; Moyed Miften; Xiaoli Yu; Oana Craciunescu; Mark Oldham; Kim Light; Terence Wong; Michael Blazing; Salvador Borges-Neto; Mark W Dewhirst; Lawrence B Marks Journal: Med Phys Date: 2005-01 Impact factor: 4.071
Authors: Charlie C Pan; Avraham Eisbruch; Julia S Lee; Rhonda M Snorrason; Randall K Ten Haken; Paul R Kileny Journal: Int J Radiat Oncol Biol Phys Date: 2005-04-01 Impact factor: 7.038
Authors: L Hong; M Goitein; M Bucciolini; R Comiskey; B Gottschalk; S Rosenthal; C Serago; M Urie Journal: Phys Med Biol Date: 1996-08 Impact factor: 3.609
Authors: Niranjan Bhandare; Laurence Kennedy; Robert S Malyapa; Christopher G Morris; William M Mendenhall Journal: Int J Radiat Oncol Biol Phys Date: 2007-04-18 Impact factor: 7.038
Authors: David C Hall; Alexei V Trofimov; Brian A Winey; Norbert J Liebsch; Harald Paganetti Journal: Int J Radiat Oncol Biol Phys Date: 2017-02-14 Impact factor: 7.038
Authors: Christian Bäumer; Sandija Plaude; Dalia Ahmad Khalil; Dirk Geismar; Paul-Heinz Kramer; Kevin Kröninger; Christian Nitsch; Jörg Wulff; Beate Timmermann Journal: Front Oncol Date: 2021-05-12 Impact factor: 6.244